Facebook: The amazing book to increase your face value!
Dinesh Chindarkar, Co-founder, MediaMedic Communications, in the series of articles titled ‘The Digital Dose for Indian Pharma’…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Clinical Research: Building Trust
With the patient standing to lose the most, it is crucial that we find common ground between the many stakeholders in the clinical…
India has a moral obligation to participate in clinical trials
Milind Rege, Clinical Team Leader – Clinical Monitoring, SIRO Clinpharm and Dr Shubhangi Desai, Head Clinical Operations - Asia…
Need to take a pragmatic view of clinical trials
Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon says that without trials there is no way pharmaceutical research can…
Without ethics, there is no credibility for clinical trials
Amar Jesani, Editor, Indian Journal of Medical Ethics, says ethical considerations are absolutely essential for upholding the…
Clinical trials: Safety of research participant is the ethical mandate!
Dr SV Joga Rao, Advocate, Solicitor & Healthcare Consultant, Legalexcel, Bengaluru, shares his experiences about the role,…
Celebrating the new era of clinical research in India on International Clinical Trials day
Paula Brown Stafford, Global Head, Clinical Development, Quintiles, gives an insight about the challenges of clinical research and…
Accident analysis
Recent explosions at pharmaceutical and chemical plants have raised serious questions over the safety procedures supposedly being…
The new patent law, policy and strategy
Anand Nandkumar, Assistant Professor of Strategy, Indian School of Business, provides an overview of the long-term implications of…
‘Tweet-talk’ your customers with new age marketing
As a continuation to the series of articles titled ‘The Digital Dose for Indian Pharma’, Dinesh Chindarkar, Co-founder & Vice…
Towards sustainable CSR
Companies will need to part with two per cent of their precious profits to fund their CSR programmes, if the new provisions of the…
SC verdict on Glivec: An IP milestone
Experts stress that the verdict should not be seen as a case of weak IP rights. An Express Pharma report
Sustainability reporting in the pharmaceutical sector: Prescription for pharma
Sustainable development is vital to not only improving a company's commitment to its stakeholders but also in reducing costs…
The case of market-based pricing
Normative practice of pricing patented articles including medicines dictates a perfect use of TRIPs flexibilities via CL. This…
EU Falsified Medicines Directive Industry proposes, Regulator disposes?
As the deadline for the implementation of the EU's Falsified Medicines Directive draws near, exporters of APIs to the EU and the…
Strategies for generic asthma inhalers: Copy or create?
Pharma companies around the world are looking for ways to address the global pulmonary drug delivery market and capitalise on long…
Digital Dose Exploring real time in Indian pharma
Dinesh Chindarkar, Co-founder, MediaMedic Communications kicks of series of articles titled ‘The Digital Dose for Indian Pharma’.
International technology transfer, FDI and development
Kamal Saggi, Professor of Economics, Vanderbilt University, gives an outlook about the strengths of Foreign Direct Investment,…
Taming MDR TB
The battle against MDR TB calls for concerted action from multiple stakeholders. Viveka Roychowdhury asks multiple stakeholders…
TB diagnosis in India Challenges and opportunities
Dr Sanjay Sarin, Regional Director, Global Health (Central & South Asia Pacific), BD elaborates on the challenges and…